MAPK14 and colorectal carcinoma: A combined risk curve and survival status analysis revealed that the corresponding middle scatter plot from left to right presented increasing death and shorter survival time trends in CRC patients, which indicated that the mortality rate in the high Mapk14 expression group was higher than that in the low expression group (Figure 3A).